SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.060
-0.180 (-5.56%)
Nov 20, 2024, 4:00 PM EST - Market closed
SAB Biotherapeutics Employees
SAB Biotherapeutics had 57 employees as of December 31, 2023. The number of employees increased by 1 or 1.79% compared to the previous year.
Employees
57
Change (1Y)
1
Growth (1Y)
1.79%
Revenue / Employee
$26,539
Profits / Employee
-$799,428
Market Cap
28.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 57 | 1 | 1.79% |
Dec 31, 2022 | 56 | -83 | -59.71% |
Dec 31, 2021 | 139 | 53 | 61.63% |
Dec 31, 2020 | 86 | - | - |
Related Stocks
Company Name | Employees |
---|---|
IRIDEX | 111 |
Precision Optics Corporation | 84 |
IceCure Medical | 77 |
DURECT | 58 |
Passage Bio | 58 |
KALA BIO | 43 |
MiNK Therapeutics | 31 |
OneMedNet | 20 |
SABS News
- 14 days ago - SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 2 months ago - SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 2 months ago - SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting - GlobeNewsWire
- 3 months ago - SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates - GlobeNewsWire
- 3 months ago - SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes - GlobeNewsWire
- 4 months ago - SAB BIO Appoints Lucy To as Chief Financial Officer - GlobeNewsWire
- 5 months ago - SAb Biotherapeutics Rebrands as SAB BIO - GlobeNewsWire
- 5 months ago - SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions - GlobeNewsWire